360 related articles for article (PubMed ID: 26667479)
1. Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications.
Pollak TA; Beck K; Irani SR; Howes OD; David AS; McGuire PK
Psychopharmacology (Berl); 2016 May; 233(9):1605-21. PubMed ID: 26667479
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond.
Kruse JL; Lapid MI; Lennon VA; Klein CJ; Toole OO; Pittock SJ; Strand EA; Frye MA; McKeon A
Psychosomatics; 2015; 56(3):227-41. PubMed ID: 25975857
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
[TBL] [Abstract][Full Text] [Related]
4. Neuronal central nervous system syndromes probably mediated by autoantibodies.
Chefdeville A; Honnorat J; Hampe CS; Desestret V
Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition.
Zuliani L; Graus F; Giometto B; Bien C; Vincent A
J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):638-45. PubMed ID: 22448032
[TBL] [Abstract][Full Text] [Related]
6. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
7. Developmental process in diffuse psychological/neuropsychiatric manifestations of neuropsychiatric systemic lupus erythematosus.
Arinuma Y; Yamaoka K
Immunol Med; 2021 Mar; 44(1):16-22. PubMed ID: 32649846
[TBL] [Abstract][Full Text] [Related]
8. Significance of Autoantibodies in Autoimmune Encephalitis in Relation to Antigen Localization: An Outline of Frequently Reported Autoantibodies with a Non-Systematic Review.
Tanaka K; Kawamura M; Sakimura K; Kato N
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668637
[TBL] [Abstract][Full Text] [Related]
9. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies and Psychosis.
Kelleher E; Barry H; Cotter DR; Corvin A; Murphy KC
Curr Top Behav Neurosci; 2020; 44():85-123. PubMed ID: 31292938
[TBL] [Abstract][Full Text] [Related]
11. [Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications].
Dalmau J; Bataller L
Neurologia; 2007 Oct; 22(8):526-37. PubMed ID: 18000762
[TBL] [Abstract][Full Text] [Related]
12. Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases.
Kaneko J; Kanazawa N; Tominaga N; Kaneko A; Suga H; Usui R; Ishima D; Kitamura E; Akutsu T; Yoshida K; Nishiyama K; Iizuka T
J Neurol Sci; 2018 Jul; 390():26-32. PubMed ID: 29801900
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic approaches in antibody-associated central nervous system pathologies.
Honnorat J
Rev Neurol (Paris); 2014 Oct; 170(10):587-94. PubMed ID: 25189679
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.
Dalmau J; Geis C; Graus F
Physiol Rev; 2017 Apr; 97(2):839-887. PubMed ID: 28298428
[TBL] [Abstract][Full Text] [Related]
15. [Update on anti-N-methyl-D-aspartate receptor encephalitis].
Kovac S; Alferink J; Ahmetspahic D; Arolt V; Melzer N
Nervenarzt; 2018 Jan; 89(1):99-112. PubMed ID: 28932896
[TBL] [Abstract][Full Text] [Related]
16. Presence of cerebrospinal fluid antibodies associated with autoimmune encephalitis of humans in dogs with neurologic disease.
Stafford EG; Kortum A; Castel A; Green L; Lau J; Early PJ; Muñana KR; Mariani CL; Yoder JA; Olby NJ
J Vet Intern Med; 2019 Sep; 33(5):2175-2182. PubMed ID: 31495976
[TBL] [Abstract][Full Text] [Related]
17. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].
Iizuka T; Sakai F
Brain Nerve; 2008 Sep; 60(9):1047-60. PubMed ID: 18807939
[TBL] [Abstract][Full Text] [Related]
18. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis.
Mikasova L; De Rossi P; Bouchet D; Georges F; Rogemond V; Didelot A; Meissirel C; Honnorat J; Groc L
Brain; 2012 May; 135(Pt 5):1606-21. PubMed ID: 22544902
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.
Dale RC; Merheb V; Pillai S; Wang D; Cantrill L; Murphy TK; Ben-Pazi H; Varadkar S; Aumann TD; Horne MK; Church AJ; Fath T; Brilot F
Brain; 2012 Nov; 135(Pt 11):3453-68. PubMed ID: 23065479
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis.
Deakin J; Lennox BR; Zandi MS
Biol Psychiatry; 2014 Feb; 75(4):284-91. PubMed ID: 23988024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
